NCT06068673View on ClinicalTrials.gov

The Potential Impact of Clindamycin on Neurosurgery Patients.

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 1, 2023

Study Completion Date

December 30, 2023

Conditions
Neurologic ComplicationNeurosurgery
Interventions
DRUG

Clindamycin 600 mg

Clindamycin 900 - 1200 mg TWICE per day during 2 weeks period.

DRUG

standard regimen

standard regimen

Trial Locations (1)

Unknown

Alexandria University Hospital, Alexandria

All Listed Sponsors
lead

Damanhour University

OTHER